The Technical Analyst
Bloomios, Inc. [BLMS]
Exchange: OTC Sector: Healthcare Industry: Drug Manufacturers—Specialty & Generic
Bloomios, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals
0.00% $0.0009
America/New_York / 1 mai 2024 @ 10:34
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 0.0580 mill |
| EPS: | -1.860 |
| P/E: | 0 |
| Earnings Date: | Mar 30, 2023 |
| SharesOutstanding: | 64.47 mill |
| Avg Daily Volume: | 0.410 mill |
| RATING 2024-05-01 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Sell | |
| Return On Equity: | Strong Buy | |
| Return On Asset: | Strong Sell | |
| DE: | Strong Sell | |
| P/E: | Sell | |
| Price To Book: | Strong Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 2/22 | 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE 29.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE 31.46 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 0.0009 - 0.0009 ( +/- 0.00%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2022-11-22 | Rohrer Douglas S | Sell | 550 000 | Stock Option Grant |
| 2022-11-22 | Rohrer Douglas S | Sell | 0 | Common Stock |
| 2021-12-15 | Emc2 Capital Llc | Sell | 0 | Common Stock |
| 2021-07-09 | Daprile Bibi | Sell | 0 | Common Stock |
| 2021-07-09 | Daprile Bibi | Sell | 95 | Series B Preferred Stock |
| INSIDER POWER |
|---|
| -100.00 |
| Last 31 transactions |
| Buy: 2 768 211 | Sell: 65 725 576 |
Forecast:
12:14 - $0.0010
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 |
| Volume Signals | |
|---|---|
| Price | $0.0009 (0.00% ) |
| Volume | 0.410 mill |
| Avg. Vol. | 0.410 mill |
| % of Avg. Vol | 100.10 % |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For BLMS
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
BLMS
Bloomios, Inc. manufactures, markets, and distributes cannabidiol products. The company's product categories include edibles, tinctures, oils, salves, capsules, balms, lotions, creams, beverages, and pet treats. It sells its hemp derived supplements and cosmetic products through wholesale and retail distribution channels. The company was formerly known as XLR Medical Corp. and changed its name to Bloomios, Inc. in April 2021. Bloomios, Inc. was incorporated in 2001 and is headquartered in Santa Barbara, California.
Latest Press Releases
2023-08-30 08:23:33 - Press Release
Bloomios Reports Q2 2023 Financial Results
Quarterly revenue more than doubles to $2.7 million year-to-date revenue up 96% to $5.4 million santa barbara, calif., august 30, 2023 – bloomios, inc. (otcqb: blms), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, reported results for the second quarter ended june 30, 2023.
2022-10-20 15:00:00 - Press Release
Bloomios To Present At The 2022 Ld Micro Main Event October 25-27
Santa barbara, california--(newsfile corp. - october 20, 2022) - bloomios, inc. (otcqb: blms), a leading hemp derived cannabinoid supplements and nutraceutical contract manufacturer specializing in full service product development, r&d and compliance solutions, has been invited to present at the ld micro 15th annual main event being held in-person on october 25-27, 2022 at the luxe sunset bel-air hotel in los angeles, california.
2022-05-25 08:31:00 - Press Release
Bloomios To Present At The 2022 Ld Micro Invitational June 7-9
Santa barbara, calif. , may 25, 2022 /prnewswire/ -- bloomios, inc. (otcqb: blms), a leading hemp and nutraceutical manufacturer specializing in full service product development, r&d and compliance solutions, has been invited to present at the 2022 ld micro invitational being held in-person at the four seasons hotel in westlake village, california on june 7-9, 2022.
Latest News
2022-10-20 15:00:00 - Newsfile Corp
Bloomios To Present at The 2022 LD Micro Main Event October 25-27
Santa Barbara, California--(Newsfile Corp. - October 20, 2022) - Bloomios, Inc. (OTCQB: BLMS), a leading hemp derived cannabinoid supplements and nutraceutical contract manufacturer specializing in full service product development, R&D and compliance solutions, has been invited to present at the LD Micro 15th Annual Main Event being held in-person on October 25-27, 2022 at the Luxe Sunset Bel-Air Hotel in Los Angeles, California.
2022-05-25 08:31:00 - PRNewsWire
Bloomios to Present at the 2022 LD Micro Invitational June 7-9
SANTA BARBARA, Calif. , May 25, 2022 /PRNewswire/ -- Bloomios, Inc. (OTCQB: BLMS), a leading hemp and nutraceutical manufacturer specializing in full service product development, R&D and compliance solutions, has been invited to present at the 2022 LD Micro Invitational being held in-person at the Four Seasons Hotel in Westlake Village, California on June 7-9, 2022.